OPTrust Private Markets Group
OPTrust invests and manages one of Canada’s largest pension funds, primarily focusing on administering the OPSEU Pension Plan. Based in Canada, OPTrust employs a diverse team of professionals dedicated to ensuring financial security for its members throughout their careers and retirement. The organization is committed to its mission of paying pensions today while preserving pensions for tomorrow, setting it apart through its emphasis on service to its members.
The firm focuses broadly on managing pension funds with particular attention to climate change strategy to fulfill their pension liabilities in a sustainable manner. It supports their mission with innovative investment management and a commitment to serving member needs. OPTrust does not provide specific information about check sizes or geographic focus but indicates a dedication to sustainable investing practices.
OPTrust Private Markets Group's investments are deeply tied to the sustainability of pensions and include collaborations aimed at climate strategies, meticulously pursuing strategic ventures for long-term growth. Given their focus on pension fund investment, individual notable portfolio companies were not specified on their site or public sources.
Optum Ventures
Optum Ventures is a venture capital firm based in Boston, founded in 2017 in partnership with UnitedHealth Group. The firm is led by Managing Partners Larry Renfro and Laura Veroneau, with a team that spans investment and operations roles. Optum Ventures stands out for its deep integration and connectivity across the healthcare ecosystem, leveraging partnerships to innovate in healthcare delivery and services.
Optum Ventures invests in companies at various stages, from seed to growth equity, focusing on the intersection of technology and healthcare. The firm has over $2 billion in assets under management distributed across six funds. Their investment sectors include value-based care delivery, enterprise software, enabling infrastructure, and fintech. The firm operates globally but maintains a strong presence in North America and Europe.
Notable investments in their portfolio include companies like Buoy - health symptom tracker, DispatchHealth - mobile urgent care, and Redox - healthcare API service. With a focus on advancing healthcare innovation, the firm works closely with entrepreneurs to address complex challenges in the healthcare industry.
Oqal
Oqal is an angel investment network based in Riyadh, Saudi Arabia, founded in 2011. The network was established by a group of young entrepreneurs with the aim of connecting angel investors with innovative startups. Oqal operates with a small team and focuses on fostering economic growth and improving the quality of life through strategic partnerships. The firm is known for its collaborative approach and strong ties with local and regional partners.
Oqal primarily invests in early-stage startups across sectors such as technology, digital services, consumer products, and financial services. The typical investment size is not explicitly mentioned, but as an angel network, it likely involves smaller check sizes typical of early-stage investments. Oqal has strategic partnerships with organizations like Monsha'at and SVC to enhance its investment capabilities and support its portfolio companies.
Notable investments by Oqal include Careem - a ride-hailing service, Hungerstation - a food delivery platform, Clara - a legal tech business, Siin - an internet retail company, and Mantas - a network management software provider. These investments highlight Oqal's commitment to high-growth sectors and its support for transformative startups within the region.
Oquendo Capital
Oquendo provides flexible capital solutions targeted at performing Iberian and French mid-market companies in the context of acquisitions, growth or shareholder reorganizations. We invest across the capital structure providing tailor made debt and equity solutions supporting financial sponsors, family owned businesses and management teams. Since 2007, Oquendo has invested in excess of €800million in 62 companies, allocating between €5 and €30 million per transaction. Oquendo is an independent company controlled by its management team and has offices in Madrid and Paris.
Orange Digital Ventures
Orange is one of the world’s leading telecommunications operators with sales of 41 billion euros in 2018 and 148,000 employees worldwide at 30 June 2019, including 89,000 employees in France. The Group has a total customer base of 266 million customers worldwide at 30 June 2018, including 207 million mobile customers and 20 million fixed broadband customers.
Orange Ventures
Orange Ventures is a venture capital firm based in Paris, operating as the investment arm of Orange Group. The firm leverages the strengths of its parent company to develop future technology champions. The team is focused on offering performance-oriented investment strategies that can foster innovation and growth within the tech industry. Orange Ventures has a global approach with an emphasis on tech startups that hold potential for significant scaling.
The firm invests across a range of sectors including AI, HealthTech, and Telecommunications, with a geographic focus that is global, but with attention to mature European tech startups capable of scaling globally. They invest in stages ranging from Series A to late-stage, with check sizes typically falling in the $10-50 m range.
Orange Ventures' portfolio includes companies like Famoco, which specializes in Android-based transaction devices, Morphisec, known for its endpoint threat prevention solutions, and Dataiku, a platform for AI and data projects. They also have investments in companies like Ringover, a CCaaS platform for SMBs, and Brut., a media brand targeting millennials and Gen Z.
Oraseya Capital
Oraseya Capital is the $136M VC fund of Dubai Integrated Economic Zones Authority, investing in early stage startups from pre Seed to Series-B.
OrbiMed
OrbiMed is a global healthcare investment firm based in New York City, founded over 25 years ago. It boasts a team of over 150 professionals, including 20 partners, bringing diverse expertise in science, medicine, investment, strategy, operations, and finance. With a commitment to build pioneering healthcare companies, OrbiMed's mission is to drive innovation and improve patient outcomes across the world.
OrbiMed invests globally across multiple segments of the healthcare industry, including biopharmaceuticals, medical devices, diagnostics, and digital health, focusing on early to late-stage opportunities. The firm manages approximately $21 billion in assets through private equity funds, public equity funds, and royalty/credit funds. Notable funds include OrbiMed Private Investments X and OrbiMed Asia Partners VI. Its investor base comprises medical institutions, university endowments, foundations, and sovereign wealth funds, reflecting a diversified and strategic partnership network.
OrbiMed's portfolio includes a variety of companies at the forefront of healthcare innovation. Key investments include Avenzo Therapeutics - oncology therapies, ADARx - RNA targeting therapies, Treeline Biosciences - oncology drug discovery, Mirador Therapeutics - precision medicine, and Insmed - biopharmaceuticals focusing on respiratory and rare diseases.
Orbit Capital
Orbit Capital is a venture debt platform headquartered in Prague and Warsaw, founded in 2019. It was established by Radovan Nešrsta, with key partners including Lukáš Macko, Wiktor Namysł, and Jerzy Rozłucki. Rozłucki, having extensive credit experience from PZU Group, adds significant depth in credit underwriting to the team. The firm distinguishes itself by being a dedicated provider of non-dilutive venture debt in Central and Eastern Europe (CEE), catering to tech companies that require growth capital without equity dilution.
The firm specializes in non-dilutive growth debt predominantly for technology companies, positioning itself in the post-Series A stage. It targets companies with at least €3 million in revenue, offering check sizes between €3-15 million. Orbit Capital focuses geographically on Central and Eastern Europe, with ambitions to extend into DACH regions. With over €200 million in assets under management across various vehicles, the firm's portfolio offers support such as international expansion, acquisitions, and working capital.
Notable investments from Orbit Capital include companies like Rohlik, which provides online grocery delivery, Twisto, a payment service, and Jutro Medical, a digital healthcare service. Additionally, its Growth Debt Fund II has invested in Sloneek, IAG, and Talkin' Things, supporting their scaling needs in the tech sector.
Orbita Capital Partners
We bring into focus the most disruptive technologies which radically change human's life
Investments which form new opportunities and minimize all the risks
Creating of global community start-ups, which originate better future for the humanity